2020
Anti-Müllerian hormone as a qualitative marker - or just quantity?
Kotlyar A, Seifer DB. Anti-Müllerian hormone as a qualitative marker - or just quantity? Current Opinion In Obstetrics & Gynecology 2020, 32: 219-226. PMID: 32205525, DOI: 10.1097/gco.0000000000000623.Peer-Reviewed Original ResearchConceptsAnti-Müllerian hormoneOvarian reserve testingClinical pregnancy rateLive birth rateOnset of menopausePremature ovarian insufficiencyNumber of oocytesSignificant predictive valueAMH levelsFertilization cyclesPregnancy rateOvarian insufficiencyIntracycle variabilityOocyte qualityPredictive valueEarly folliclesFetal trisomiesHormoneReproductive technologiesRiskQualitative markersSmall interMenopauseInsufficiencyFollicles
2018
National survey of the Society for Assisted Reproductive Technology membership regarding insurance coverage for assisted reproductive technologies
Seifer DB, Wantman E, Sparks AE, Luke B, Doody KJ, Toner JP, van Voorhis BJ, Lin PC, Reindollar RH. National survey of the Society for Assisted Reproductive Technology membership regarding insurance coverage for assisted reproductive technologies. Fertility And Sterility 2018, 110: 1081-1088.e1. PMID: 30396552, DOI: 10.1016/j.fertnstert.2018.07.016.Peer-Reviewed Original ResearchConceptsElective single embryo transferHigh annual volumeInsurance coverageInfertility insurance coverageVulnerable populationsMultivariable logistic regressionOverall response rateSingle embryo transferReproductive technologiesSignificant predictive valueFertility preservationCancer patientsOdds ratioTransgender patientsMAIN OUTCOMEPredictive valueResponse rateNumber of casesPatientsPractice settingsLogistic regressionUninsured populationAnnual volumeMajority of respondentsGenetic disorders